Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 3 ENHANCE-2 trial on target to report top-line COPD data in … Continue reading “Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update”